Nplate Approval History
FDA Approved: Yes (First approved August 22, 2008)
Brand name: Nplate
Generic name: romiplostim
Company: Amgen Inc.
Treatment for: Idiopathic Thrombocytopenic Purpura
Nplate (romiplostim) is a thrombopoietin mimetic peptibody for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP).
Development History and FDA Approval Process for Nplate
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.